8-Ethyl-2-methanethio-8H-pyrido[2,3-d]pyrimidin-7-one, 96%, 250mg

4,5,6,7-Tetrahydro-3-(trifluoromethyl)-1H-indazole, 95.0%, 1g

4-BROMO-7-(TRIFLUOROMETHYL)-1H-INDAZOLE, 95%, 250mg

Extraction system Model AC, AC 04, 1 piece

Ethyl 5-amino-1-(4-bromophenyl)-1H-pyrazole-4-carboxylate, 95.0%, 1g

2-Hydroxy-3-methoxy-5-nitrobenzaldehyde, 98.0%, 10g

2,3,6-Trifluorophenol, 98.0%, 10g

3-Ethoxycarbonyl-5,6-dihydro-2-methyl-4H-pyran, 97.0%, 5g

2,6-Dichlorophenylhydrazine hydrochloride, 98.0%, 500g

3-(ethoxycarbonyl)-1-(4-ethoxyphenyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 5g

1-Methyl-1H-pyrazole-3-sulfonyl chloride, 95.0%, 10g

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 4 - MWCO 12,000 to 14,000, 75 mm, 15 m, 1 Piece(s)

4-Chloronicotinamide, 97.0%, 25g